BioNexus Gene Lab (BGLC) Inventory Average (2019 - 2026)

BioNexus Gene Lab's Inventory Average history runs 8 years deep, the most recent figure standing at $671928.5 for Q1 2026.

• In Q1 2026, Inventory Average fell 47.66% year-over-year to $671928.5; the TTM figure through Mar 2026 stood at $671928.5 (down 47.66% YoY), while the FY2025 annual figure was $1.0 million, down 18.25% from the prior year.
• Inventory Average came in at $671928.5 for Q1 2026 at BioNexus Gene Lab, down from $842075.5 in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $1.6 million in Q1 2022 to a low of $671928.5 in Q1 2026.
• A 5-year average of $1.2 million and a median of $1.1 million in 2023 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average increased 23.69% in 2024 and sank 47.66% in 2026, its largest moves.
• BioNexus Gene Lab's Inventory Average stood at $1.0 million in 2022, then climbed by 8.29% to $1.1 million in 2023, then climbed by 23.69% to $1.4 million in 2024, then slumped by 39.37% to $842075.5 in 2025, then dropped by 20.21% to $671928.5 in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $671928.5, $842075.5, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison